Tax
State & Local Tax (Deferred)
Vertex Pharmaceuticals State & Local Tax (Deferred) remained flat by 0.0% to -$5.53M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 54.6%, from -$12.18M to -$5.53M. Over 2 years (FY 2023 to FY 2025), State & Local Tax (Deferred) shows relatively stable performance with a 0.5% CAGR.
Analysis
StatementIncome Statement
SectionTax
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
Changes reflect the impact of state-specific tax laws on the timing of tax payments.
Detailed definition
The portion of the income tax provision that is deferred to future periods due to temporary differences between financia...
Peer comparison
Standard tax disclosure for companies with significant regional operations.
Metric ID:
msft_deferred_state_and_local_tax_expenseHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | -$21.90M | -$48.70M | -$22.10M |
| YoY Change | — | -122.4% | +54.6% |
Range-$48.70M – -$21.90M
CAGR+0.5%
Avg YoY Growth-33.9%
Median YoY Growth-33.9%
State & Local Tax (Deferred) at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's state & local tax (deferred)?
- Vertex Pharmaceuticals (VRTX) reported state & local tax (deferred) of -$5.53M in Q4 2025.
- How has Vertex Pharmaceuticals's state & local tax (deferred) changed year-over-year?
- Vertex Pharmaceuticals's state & local tax (deferred) increased by 54.6% year-over-year, from -$12.18M to -$5.53M.
- What is the long-term trend for Vertex Pharmaceuticals's state & local tax (deferred)?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's state & local tax (deferred) has grown at a 0.5% compound annual growth rate (CAGR), from -$21.90M to -$22.10M.
- What does state & local tax (deferred) mean?
- State and local taxes that are recognized in the current period but will be paid or realized in future periods.